A Study to Examine the Effect of Daridorexant on the Way the Body Absorbs, Distributes, and Gets Rid of Midazolam and Warfarin in Healthy Male Subjects

Subjects will receive a single oral dose of 2 mg midazolam (Treatment A, B, and C).

Subjects will receive a single oral dose of 25 mg warfarin (Treatment A and B).

Subjects will receive an o.d. oral dose of 50 mg daridorexant from Day 1 to Day 7 of Treatment B and a single oral dose of 50 mg daridorexant on Day 1 of Treatment C.